Clinical Trials Browser

NIH × Leukemia, Biphenotypic, Acute × Clofarabine × Clear all

NCT01132573 2014-07-17

Entinostat and Clofarabine in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Poor-Risk Acute Lymphoblastic Leukemia or Bilineage/Biphenotypic Leukemia

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma